SOX2 activation in this population, combined with an oncogene, results in a clonal behaviour similar to the K14/K5+ tumour-primed population and promotes the re-acquisition of stemness and tumour-initiating capabilities in the skin's basal compartment. This evidence concerns the gene KRT5 and neoplasm.